{"@id":"https://bioecon.ru/technology/bioactive-folates-for-eye-disease-autism/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/bioactive-folates-for-eye-disease-autism/","json":"https://cn.bioecon.ru/api/v1/technology/bioactive-folates-for-eye-disease-autism/index.json"},"id":"bioactive-folates-for-eye-disease-autism","industries":["pharma","wellness-prevention","longevity","food-ingredients"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/wellness-prevention/","https://bioecon.ru/industries/longevity/","https://bioecon.ru/industries/food-ingredients/"],"suppliers":["https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/pacific-biochar/","https://bioecon.ru/companies/stryker/","https://bioecon.ru/companies/brain-biotech/","https://bioecon.ru/companies/berkem-groupe/","https://bioecon.ru/companies/en-bio-tech/","https://bioecon.ru/companies/shree-renuka-sugars/","https://bioecon.ru/companies/alcon/"]},"maturity":9,"name":"高光学纯度单一非对映异构体（6S）-5-甲基四氢叶酸钙在神经眼科与自闭症谱系障碍中的干预技术","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"非对映选择性催化合成与超高光学纯度手性结晶"},{"n":2,"title":"耐热抗氧化型无水结晶钙盐与氨基葡萄糖盐固化"},{"n":3,"title":"神经元血脑屏障叶酸受体α（FRα）特异性转运确证"},{"n":4,"title":"儿童自闭症与脑叶酸缺乏症临床神经发育干预验证"}],"summary":"突破传统叶酸无法穿透代谢基因多态性障碍的技术瓶颈，采用手性催化拆分与结晶控型工艺，工业级制造高化学稳定性、高晶型纯度的单一（6S）-5-甲基四氢叶酸钙盐微囊制剂。该活性叶酸形式无需体内MTHFR酶还原转化，可经叶酸受体α介导直接穿透血脑屏障与血视网膜屏障，纠正大脑与黄斑区一碳单位叶酸缺乏，在儿童自闭症谱系障碍（ASD）、脑叶酸缺乏综合征及视神经退行性病变中发挥显著神经保护作用。","url":"/technology/bioactive-folates-for-eye-disease-autism/","verified":"2026-11-22"}